25350 Federal Register / Vol. 65, No. 84 / Monday, May 1, 2000 / Notices

2For FY 1999, Havana Parolee arrivals for all States are based on actual data. For FY 1998, Florida’s HP’s (10,183) are based on actual data,

while HP’s in other States (3,258) are prorated according to the State’s proportion of the three-year (FY 1996-FY 1998) entrant population. For

FY 1997, Florida’s HP’s (3,957) are based on actual data, while HP’s in other States (2,035) were prorated according to their proportions of the

three-year entrant population. 3Alaska and Wyoming no longer participate in the Refugee Program.

4The allocation for Idaho is expected to be awarded to the State replacement designee.

5The allocations for South Dakota, Kentucky, and Nevada are expected to be awarded to Wilson/Fish projects.

VI. Paperwork Reduction Act

This notice does not create any

reporting or recordkeeping requirements

requiring OMB clearance.

[Catalog of Federal Domestic Assistance No.

93.566 Refugee Assistance—State

Administered Programs]

Dated: April 25, 2000.

Lavinia Limo ́n,

Director, Office of Refugee Resettlement.

[FR Doc. 00–10783 Filed 4–28–00; 8:45 am]

BILLING CODE 4184–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS.

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be listed at the end, and will be omitted

from the monthly listing thereafter.

This Notice is available on the

internet at the following website:

http://wmcare.samhsa.gov

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, 5600

Fishers Lane, Rockwall 2 Building,

Room 815, Rockville, Maryland 20857;

Tel.: (301) 443–6014, Fax: (301) 443–

3031.

Special Note: Please use the above address

for all surface mail and correspondence. For

all overnight mail service use the following

address: Division of Workplace Programs,

5515 Security Lane, Room 815, Rockville,

Maryland 20852.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACL Laboratories, 8901 W. Lincoln Ave.,

West Allis, WI 53227, 414–328–7840/800–

877–7016, (Formerly: Bayshore Clinical

Laboratory)

Advanced Toxicology Network, 3560 Air

Center Cove, Suite 101, Memphis, TN

38118, 901–794–5770/888–290–1150

Aegis Analytical Laboratories, Inc., 345 Hill

Ave., Nashville, TN 37210, 615–255–2400

Alabama Reference Laboratories, Inc., 543

South Hull St., Montgomery, AL 36103,

800–541–4931/334–263–5745

Alliance Laboratory Services, 3200 Burnet

Ave., Cincinnati, OH 45229, 513–585–

9000, (Formerly: Jewish Hospital of

Cincinnati, Inc.)

American Medical Laboratories, Inc., 14225

Newbrook Dr., Chantilly, VA 20151, 703–

802–6900

Associated Pathologists Laboratories, Inc.,

4230 South Burnham Ave., Suite 250, Las

Vegas, NV 89119–5412, 702–733–7866/

800–433–2750

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little Rock,

AR 72205–7299, 501–202–2783, (Formerly:

Forensic Toxicology Laboratory Baptist

Medical Center)

Clinical Reference Lab, 8433 Quivira Rd.,

Lenexa, KS 66215–2802, 800–445–6917

Cox Health Systems, Department of

Toxicology, 1423 North Jefferson Ave.,

Springfield, MO 65802, 800–876–3652/

417–269–3093, (Formerly: Cox Medical

Centers)

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, P. O. Box 88–

6819, Great Lakes, IL 60088–6819, 847–

688–2045/847–688–4171

Diagnostic Services Inc., dba DSI, 12700

Westlinks Drive, Fort Myers, FL 33913,

941–561–8200/800–735–5416

Doctors Laboratory, Inc., P.O. Box 2658, 2906

Julia Dr., Valdosta, GA 31604, 912–244–

4468

DrugProof, Division of Dynacare/Laboratory

of Pathology, LLC, 1229 Madison St., Suite

500, Nordstrom Medical Tower, Seattle,

WA 98104, 206–386–2672/800–898–0180,

(Formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle, Inc.)

DrugScan, Inc., P.O. Box 2969, 1119 Mearns

Rd., Warminster, PA 18974, 215–674–9310

Dynacare Kasper Medical Laboratories *,

14940–123 Ave., Edmonton, Alberta,

Canada T5V 1B4, 80–451–3702/800–661–

9876

ElSohly Laboratories, Inc., 5 Industrial Park

Dr., Oxford, MS 38655, 601–236–2609

Gamma-Dynacare Medical Laboratories *, A

Division of the Gamma-Dynacare

Laboratory Partnership, 245 Pall Mall St.,

London, ON Canada N6A 1P4, 519–679–

1630

General Medical Laboratories, 36 South

Brooks St., Madison, WI 53715, 608–267–

6267

Hartford Hospital Toxicology Laboratory, 80

Seymour St., Hartford, CT 06102–5037,

860–545–6023

Integrated Regional Laboratories, 5361 NW

33rd Avenue, Fort Lauderdale, FL 33309,

954–777–0018, 800–522–0232, (Formerly:

Cedars Medical Center, Department of

Pathology)

Kroll Laboratory Specialists, Inc., 1111

Newton St., Gretna, LA 70053, 504–361–

8989/800–433–3823, (Formerly: Laboratory

Specialists, Inc.)

LabOne, Inc., 10101 Renner Blvd., Lenexa,

KS 66219, 913–888–3927/800–728–4064,

(Formerly: Center for Laboratory Services,

a Division of LabOne, Inc.)

Laboratory Corporation of America Holdings,

1904 Alexander Drive, Research Triangle

Park, NC 27709, 919–572–6900/800–833–

3984, (Formerly: LabCorp Occupational

Testing Services, Inc., CompuChem

Laboratories, Inc.; CompuChem

Laboratories, Inc., A Subsidiary of Roche

Federal Register / Vol. 65, No. 84 / Monday, May 1, 2000 / Notices 25351

Biomedical Laboratory; Roche

CompuChem Laboratories, Inc., A Member

of the Roche Group)

Laboratory Corporation of America Holdings,

4022 Willow Lake Blvd., Memphis, TN

38118, 901–795–1515/800–233–6339

(Formerly: LabCorp Occupational Testing

Services, Inc., MedExpress/National

Laboratory Center)

Laboratory Corporation of America Holdings,

69 First Ave., Raritan, NJ 08869, 908–526–

2400/800–437–4986, (Formerly: Roche

Biomedical Laboratories, Inc.)

Marshfield Laboratories, Forensic Toxicology

Laboratory, 1000 North Oak Ave.,

Marshfield, WI 54449, 715–389–3734/800–

331–3734

MAXXAM Analytics Inc.*, 5540 McAdam

Rd., Mississauga, ON, Canada L4Z 1P1,

905–890–2555, (Formerly: NOVAMANN

(Ontario) Inc.)

Medical College Hospitals Toxicology

Laboratory, Department of Pathology, 3000

Arlington Ave., Toledo, OH 43614, 419–

383–5213

MedTox Laboratories, Inc., 402 W. County

Rd. D, St. Paul, MN 55112, 651–636–7466/

800–832–3244

MetroLab-Legacy Laboratory Services, 1225

NE 2nd Ave., Portland, OR 97232, 503–

413–5295/800–950–5295

Minneapolis Veterans Affairs Medical Center,

Forensic Toxicology Laboratory, 1 Veterans

Drive, Minneapolis, Minnesota 55417,

612–725–2088

National Toxicology Laboratories, Inc., 1100

California Ave., Bakersfield, CA 93304,

661–322–4250

NWT Drug Testing, 1141 E. 3900 South, Salt

Lake City, UT 84124, 801–268–2431/800–

322–3361, (Formerly: NorthWest

Toxicology, Inc.)

One Source Toxicology Laboratory, Inc., 1705

Center Street, Deer Park, TX 77536, 713–

920–2559, (Formerly: University of Texas

Medical Branch, Clinical Chemistry

Division; UTMB Pathology-Toxicology

Laboratory)

Oregon Medical Laboratories, P.O. Box 972,

722 East 11th Ave., Eugene, OR 97440–

0972, 541–687–2134

Pacific Toxicology Laboratories, 6160 Variel

Ave., Woodland Hills, CA 91367, 818–598–

3110, (Formerly: Centinela Hospital

Airport Toxicology Laboratory

Pathology Associates Medical Laboratories,

11604 E. Indiana, Spokane, WA 99206,

509–926–2400/800–541–7891

PharmChem Laboratories, Inc., 1505–A

O’Brien Dr., Menlo Park, CA 94025, 650–

328–6200/800–446–5177

PharmChem Laboratories, Inc., Texas

Division, 7606 Pebble Dr., Fort Worth, TX

76118, 817–215–8800, (Formerly: Harris

Medical Laboratory)

Physicians Reference Laboratory, 7800 West

110th St., Overland Park, KS 66210, 913–

339–0372/800–821–3627

Poisonlab, Inc., 7272 Clairemont Mesa Blvd.,

San Diego, CA 92111, 619–279–2600/800–

882–7272

Quest Diagnostics Incorporated, 3175

Presidential Dr., Atlanta, GA 30340, 770–

452–1590, (Formerly: SmithKline Beecham

Clinical Laboratories, SmithKline BioScience Laboratories)

Quest Diagnostics Incorporated, 4444

Giddings Road, Auburn Hills, MI 48326,

810–373–9120/800–444–0106, (Formerly:

HealthCare/Preferred Laboratories,

HealthCare/MetPath, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, National

Center for Forensic Science, 1901 Sulphur

Spring Rd., Baltimore, MD 21227, 410–

536–1485, (Formerly: Maryland Medical

Laboratory, Inc., National Center for

Forensic Science, CORNING National

Center for Forensic Science)

Quest Diagnostics Incorporated, 8000

Sovereign Row, Dallas, TX 75247, 214–

638–1301, (Formerly: SmithKline Beecham

Clinical Laboratories, SmithKline BioScience Laboratories)

Quest Diagnostics Incorporated, 4770 Regent

Blvd., Irving, TX 75063, 972–916–3376/

800–526–0947, (Formerly: Damon Clinical

Laboratories, Damon/MetPath, CORNING

Clinical Laboratories)

Quest Diagnostics Incorporated, 801 East

Dixie Ave., Leesburg, FL 34748, 352–787–

9006, (Formerly: SmithKline Beecham

Clinical Laboratories, Doctors & Physicians

Laboratory)

Quest Diagnostics Incorporated, 400 Egypt

Rd., Norristown, PA 19403, 610–631–4600/

800–877–7484, (Formerly: SmithKline

Beecham Clinical Laboratories, SmithKline

Bio-Science Laboratories)

Quest Diagnostics Incorporated, 506 E. State

Pkwy., Schaumburg, IL 60173, 800–669–

6995/847–885–2010, (Formerly:

SmithKline Beecham Clinical Laboratories,

International Toxicology Laboratories)

Quest Diagnostics Incorporated, 7470

Mission Valley Rd., San Diego, CA 92108–

4406, 619–686–3200/800–446–4728,

(Formerly: Nichols Institute, Nichols

Institute Substance Abuse Testing (NISAT),

CORNING Nichols Institute, CORNING

Clinical Laboratories)

Quest Diagnostics Incorporated, One

Malcolm Ave., Teterboro, NJ 07608, 201–

393–5590, (Formerly: MetPath, Inc.,

CORNING MetPath Clinical Laboratories,

CORNING Clinical Laboratory)

Quest Diagnostics Incorporated, 7600 Tyrone

Ave., Van Nuys, CA 91405, 818–989–2520/

800–877–2520, (Formerly: SmithKline

Beecham Clinical Laboratories)

San Diego Reference Laboratory, 6122 Nancy

Ridge Dr., San Diego, CA 92121, 800–677–

7995

Scientific Testing Laboratories, Inc., 463

Southlake Blvd., Richmond, VA 23236,

804–378–9130

Scott & White Drug Testing Laboratory, 600

S. 25th St., Temple, TX 76504, 254–771–

8379/800–749–3788

S.E.D. Medical Laboratories, 5601 Office

Blvd., Albuquerque, NM 87109, 505–727–

6300/800–999–5227

South Bend Medical Foundation, Inc., 530 N.

Lafayette Blvd., South Bend, IN 46601,

219–234–4176

Southwest Laboratories, 2727 W. Baseline

Rd., Tempe, AZ 85283, 602–438–8507

Sparrow Health System, Toxicology Testing

Center, St. Lawrence Campus, 1210 W.

Saginaw, Lansing, MI 48915, 517–377–

0520, (Formerly: St. Lawrence Hospital &

Healthcare System)

St. Anthony Hospital Toxicology Laboratory,

1000 N. Lee St., Oklahoma City, OK 73101,

405–272–7052

Toxicology & Drug Monitoring Laboratory,

University of Missouri Hospital & Clinics,

2703 Clark Lane, Suite B, Lower Level,

Columbia, MO 65202, 573–882–1273

Toxicology Testing Service, Inc., 5426 N.W.

79th Ave., Miami, FL 33166, 305–593–

2260

UNILAB, 18408 Oxnard St., Tarzana, CA

91356, 818–996–7300/800–492–0800,

(Formerly: MetWest-BPL Toxicology

Laboratory)

Universal Toxicology Laboratories, LLC,

10210 W. Highway 80, Midland, Texas

79706, 915–561–8851/888–953–8851

The following laboratory voluntarily

withdrew from the NLCP program,

effective May 1, 2000:

Quest Diagnostics Incorporated, 875

Greentree Rd., 4 Parkway Ctr., Pittsburgh,

PA 15220–3610, 412–920–7733/800–574–

2474, (Formerly: Med-Chek Laboratories,

Inc., Med-Chek/Damon, MetPath

Laboratories, CORNING Clinical

Laboratories)

*The Standards Council of Canada (SCC)

voted to end its Laboratory Accreditation

Program for Substance Abuse (LAPSA)

effective May 12, 1998. Laboratories certified

through that program were accredited to

conduct forensic urine drug testing as

required by U.S. Department of

Transportation (DOT) regulations. As of that

date, the certification of those accredited

Canadian laboratories will continue under

DOT authority. The responsibility for

conducting quarterly performance testing

plus periodic on-site inspections of those

LAPSA-accredited laboratories was

transferred to the U.S. DHHS, with the

DHHS’ National Laboratory Certification

Program (NLCP) contractor continuing to

have an active role in the performance testing

and laboratory inspection processes. Other

Canadian laboratories wishing to be

considered for the NLCP may apply directly

to the NLCP contractor just as U.S.

laboratories do.

Upon finding a Canadian laboratory to be

qualified, the DHHS will recommend that

DOT certify the laboratory (Federal Register,

16 July 1996) as meeting the minimum

standards of the ‘‘Mandatory Guidelines for

Workplace Drug Testing’’ (59 Federal

Register, 9 June 1994, Pages 29908–29931).

After receiving the DOT certification, the

laboratory will be included in the monthly

list of DHHS certified laboratories and

participate in the NLCP certification

maintenance program.

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 00–10489 Filed 4–28–00; 8:45 am]

BILLING CODE 4160–20–U